Oxford Pharmaceuticals, LLC

Oxford Pharmaceuticals, LLC is a generic drug manufacturer located in Birmingham, AL with a mission to provide affordable, high-quality generic drug products to improve patient lives. The company's $30 million, state-of-the-art 150,000 sq. ft facility was FDA approved in 2019, demonstrating their commitment to product quality and safety. With a focus on cost-effective manufacturing capabilities, Oxford Pharmaceuticals is launching a diverse portfolio of over 30+ generic pharmaceutical products, leveraging their in-house service delivery distribution channel for maximum profitability. The company has seen continued growth, even amidst the pandemic, and currently employs approximately 200 people. Additionally, the company's tie to its UK investor and CEO, an Oxford, England Scholar, provides a unique global perspective to their operations. With a strong emphasis on compliance with Good Manufacturing Practices (GMP), Oxford Pharmaceuticals is poised for success in the generic drug market, offering a reliable and cost-competitive option for patients and customers.